| Description | Coenzyme Q10 (ubiquinone) is a naturally occurring compound widely distributed in animal organisms and in animals. The primary compounds involved in the biosynthesis of ubiquinone are 4-hydroxybenzoate and the polyprenyl chain. An essential role of coenzyme Q10 is as an electron carrier in the mitochondrial respiratory chain. Moreover, coenzyme Q10 is one of the most important lipophilic antioxidants, preventing the generation of free radicals as well as oxidative modifications of proteins, lipids, and DNA, it and can also regenerate the other powerful lipophilic antioxidant, alpha-tocopherol. Antioxidant action is a property of the reduced form of coenzyme Q10, ubiquinol (CoQ10H2), and the ubisemiquinone radical (CoQ10H*). Paradoxically, independently of the known antioxidant properties of coenzyme Q10, the ubisemiquinone radical anion (CoQ10-) possesses prooxidative properties. Decreased levels of coenzyme Q10 in animals are observed in many pathologies (e.g. cardiac disorders, neurodegenerative diseases, AIDS, cancer) associated with intensive generation of free radicals and their action on cells and tissues. In these cases, treatment involves pharmaceutical supplementation or increased consumption of coenzyme Q10 with meals as well as treatment with suitable chemical compounds (i.e. folic acid or B-group vitamins) which significantly increase ubiquinone biosynthesis in the organism. Estimation of coenzyme Q10 deficiency and efficiency of its supplementation requires a determination of ubiquinone levels in the organism. Therefore, highly selective and sensitive methods must be applied, such as HPLC with UV or coulometric detection. For a number of years, coenzyme Q (CoQ10 in animals) was known for its key role in mitochondrial bioenergetics; later studies demonstrated its presence in other subcellular fractions and in plasma, and extensively investigated its antioxidant role. These two functions constitute the basis on which research supporting the clinical use of CoQ10 is founded. Also at the inner mitochondrial membrane level, coenzyme Q is recognized as an obligatory co-factor for the function of uncoupling proteins and a modulator of the transition pore. Furthermore, recent data reveal that CoQ10 affects expression of genes involved in animal cell signalling, metabolism, and transport and some of the effects of exogenously administered CoQ10 may be due to this property. Coenzyme Q is the only lipid soluble antioxidant synthesized endogenously. In its reduced form, CoQH2, ubiquinol, inhibits protein and DNA oxidation but it is the effect on lipid peroxidation that has been most deeply studied. Ubiquinol inhibits the peroxidation of cell membrane lipids and also that of lipoprotein lipids present in the circulation. Dietary supplementation with CoQ10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of animal low-density lipoproteins to the initiation of lipid peroxidation. Moreover, CoQ10 has a direct anti-atherogenic effect, which has been demonstrated in apolipoprotein E-deficient mice fed with a high-fat diet. (PMID: 15928598 , 17914161 ). |
|---|
| Synonyms | | Value | Source |
|---|
| Coenzyme Q10 semiquinone | HMDB | | Ubidecarenone | MeSH, HMDB | | Coenzyme Q10, (Z,Z,Z,Z,Z,Z,e,e,e)-isomer | MeSH, HMDB | | Ubisemiquinone radical | MeSH, HMDB | | 2,3-Dimethoxy-5-methyl-6-decaprenylbenzoquinone | MeSH, HMDB | | CoQ10 | MeSH, HMDB | | Q-Ter | MeSH, HMDB | | CO-Enzyme Q10 | MeSH, HMDB | | Coenzyme Q10 | MeSH | | bio-Quinone Q10 | MeSH, HMDB | | Ubiquinone 50 | MeSH, HMDB | | CoQ 10 | MeSH, HMDB | | Coenzyme Q10, ion (1-), (all-e)-isomer | MeSH, HMDB | | Ubiquinone Q10 | MeSH, HMDB | | 2-((all-e)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone | HMDB | | 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone | HMDB | | Adelir | HMDB | | all-trans-Ubiquinone | HMDB | | CoQ | HMDB | | Q | HMDB | | Q 199 | HMDB | | Q10 | HMDB | | Ubiquinone | HMDB | | Ubiquinone 10 | HMDB, MeSH | | UBIQUINONE-10 | HMDB | | (all-e)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-cyclohexadiene-1,4-dione | HMDB | | (all-e)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione | HMDB | | 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone | HMDB | | 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-cyclohexadiene-1,4-dione | HMDB | | 4-Ethyl-5-fluoropyrimidine | HMDB | | Aqua Q 10l10 | HMDB | | Aqua Q10 | HMDB | | Bio-quinon | HMDB | | Ensorb | HMDB | | Kaneka Q10 | HMDB | | Kudesan | HMDB | | Li-Q-sorb | HMDB | | Liquid-Q | HMDB | | Neuquinon | HMDB | | Neuquinone | HMDB | | PureSorb Q 40 | HMDB | | Q 10AA | HMDB | | Q-Gel | HMDB | | Q-Gel 100 | HMDB | | Unbiquinone | HMDB | | Unispheres Q 10 | HMDB | | Ubisemiquinone | HMDB, MeSH |
|
|---|
| InChI Identifier | InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+ |
|---|
